Skip to content

This Site is Intended for Healthcare Professionals Only

Search AI Powered

Latest Stories

PSNC appoints Robbie Turner as chief transformation officer

The Pharmaceutical Services Negotiating Committee (PSNC) has appointed Robbie Turner as chief transformation officer, to work closely with LPCs as part of its newly launched Transforming Pharmacy Representation (TAPR) programme.

PSNC launched the TAPR Programme in response to the contractor vote in favour of the Review Steering Group’s proposals. As part of the programme – alongside actioning the recommendations for PSNC – there will be support for LPCs to implement their proposals.


Turner will be responsible for leading, driving, and having oversight of the TAPR workstream to increase efficiency and outcomes across the network of LPCs in England.

This will include the provision of specialist hands-on guidance and support to LPC members and officers, to promote implementation of the RSG proposals, best practice and challenging the status quo.

Turner was formerly chief officer of Community Pharmacy West Yorkshire LPC and subsequently Director for England and Director of Pharmacy and Member Experience at the Royal Pharmaceutical Society.

PSNC says this appointment is a significant step in TAPR work – contractors can expect further updates in the coming weeks as well as a more detailed action plan by the end of September.

Commenting on his new role, Turner, PSNC chief transformation officer, said: “I’m delighted to be joining PSNC at this exciting time for PSNC, the LPCs and the community pharmacy sector. I’m looking forward to working closely with many of my former colleagues in LPCs again. There is much to be done at a local level to implement the RSG proposals and I will be reaching out to LPCs very soon about how I can support them through this process.”

James Wood, PSNC director of Contractor and LPC Support, said: “We’re really excited to have Robbie joining us at this critical point for LPCs and PSNC as we look to make positive changes following the outcomes of the RSG work. Robbie brings a huge amount of experience, enthusiasm, and credibility to this piece of work. He will be well known to many in pharmacy, and his experience in bringing together LPCs for the benefit of contractors in Yorkshire will be invaluable to other LPCs as they look to the changes ahead.”

On the 4 March 2022, RPS announced that Robbie Turner had decided to leave his role as director of Pharmacy and Membership Experience at the Society. His last day in RPS was 31 March 2022.

More For You

NHS to invest millions to boost enhanced treatment for sickle cell patients

Approximately 17,000 people live in England with sickle cell disease

Pic credit: istock

NHS to invest millions to boost enhanced treatment for sickle cell patients

The Department of Health and Social Care has announced that it will invest £9 million towards the treatment of sickle cell patients.

Approximately 17,000 people live in England with sickle cell disease. Nearly 250 new cases of this inherited blood disorder is reported annually.

Keep ReadingShow less
NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients

An estimated 6,000 cases of multiple myeloma is diagnosed in the UK each year.

Pic credit: istock

NHS leads the world with new ‘trojan horse’ therapy for blood cancer patients


NHS England has become the first in the world to introduce a ‘trojan horse’ therapy for the victims of blood cancer with the ground-breaking treatment slowing down the illness three-times more than existing treatments.

Keep ReadingShow less
Call to improve inclusivity in clinical research

Ethnic minority adults continue to be underrepresented in clinical trials.

iStock

Call to improve inclusivity in clinical research

A NEW report has called for the participation of a wide range of diverse communities in clinical research to make sure that the medicines meet the needs of the UK's increasingly diverse population.

The report ‘Achieving inclusivity in clinical research’, prepared by the Association of the British Pharmaceutical Industry (ABPI) and the Association of Medical Research Charities (AMRC), highlights the long-standing challenges in ensuring diversity in clinical trials.

Keep ReadingShow less
Pharmacy students Learning Support Fund

Pharmacy students will be included in the Travel and Dual Accommodation Expenses section of the NHS Learning Support Fund.

iStock

Pharmacy students to have access to Learning Support Fund

FOR the first time in England, pharmacy students will be eligible to reimburse travel and accommodation costs while attending placements.

The Department of Health and Social Care confirmed that pharmacy students would finally be included in the Travel and Dual Accommodation Expenses (TDAE) section of the NHS Learning Support Fund (LSF).

Keep ReadingShow less
NHS for robotic surgery

Patients undergoing robotic surgery are able to recover quicker and be discharged sooner.

Pic credit: iStock

NHS pushes for robotic surgery to reduce waiting time, improve outcomes

The NHS is planning to step up robotic surgery over the next decade to reduce waiting time, help in the speed of recovery of patients, and shorter hospital stay.

As per the NHS projections, the number is expected to zoom from 70,000 in 2023/24 to half a million by 2035.

Keep ReadingShow less